04
Feb

The FDA rejected IntelGenx and RedHill Biopharma’s dissolvable migraine treatment VersaFilm due to problems with a third-party manufacturer, the companies said. The two still believe they can sway regulators and get the drug on the U.S. market.

…read more

Source: FDA rejects IntelGenx and RedHill’s migraine film

    

0 No comments